In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Faust gets €16mm in second round private placement

Executive Summary

Faust Pharmaceuticals (drugs for chronic CNS disorders) raised €16mm ($18.99mm) in its second round private placement. The company's existing investors Sofinnova Partners and Auriga Partners contributed a total of €6.5mm, while new investors Edmond de Rothschild Investment, Siparex Ventures, AGF Private Equity, and FCJE (managed by FP Gestion) bought €9.5mm worth of equity.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies